ArticlePLoS medicine2024
Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act.
Robin FeldmanPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it